Who is sponsoring NCT05064215?

NCT05064215 is sponsored by Dr. Elisabeth Würinger.

What drugs are being tested in NCT05064215?

Interventions in NCT05064215: anatomical examination.

What condition does NCT05064215 study?

NCT05064215 studies Lymph Drainage of Breast.

Is NCT05064215 still recruiting?

NCT05064215 is currently completed. Last updated 1 October 2021.

Last reviewed 2021-10-01 · How we verify

NCT05064215

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Lymphatic Drainage of the Breast, a Retrospective Assessment of Data

Completed Last updated 1 October 2021

What this trial tests

trial testing anatomical examination in Lymph Drainage of Breast in 14 participants. Completed in 10 August 2021.

Timeline

25 May 2021

Primary endpoint
10 July 2021

10 August 2021

Quick facts

Lead sponsor	Dr. Elisabeth Würinger
Status	Completed
Study type	OBSERVATIONAL
Enrollment	14
Start date	25 May 2021
Primary completion	10 July 2021
Estimated completion	10 August 2021
Sites	1 location across Austria

Drugs / interventions tested

anatomical examination

Conditions studied

Lymph Drainage of Breast — all drugs for Lymph Drainage of Breast →

Sponsor

Dr. Elisabeth Würinger

Who can join

20 and older, female only, with Lymph Drainage of Breast. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

retrospective evaluation of patients, in whom blue colour was injected into different sites of the breast before breast reduction, to investigate direction and localisation of lymphatic flow. Investigations were performed at the Wilhelminenspital, Vienna, in the years 1998 to 2009.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

Localization of Central Breast Lymphatics and Predefined Separation of Lobes along the Horizontal Septum.
Würinger E. · · 2023 · cited 2× · PMID 38074493 · DOI 10.1097/gox.0000000000005446

Verify or expand the search:

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT05064215 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Dr. Elisabeth Würinger
Last refreshed: 1 October 2021

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05064215.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing